{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:40:26Z","timestamp":1791211226189,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2009,8,25]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      <jats:italic>Background\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    Early case detection is vital in rheumatic heart disease (RHD) in children to minimize the risk of advanced valvular heart disease by preventive measures. The currently utilized World Health Organization (WHO) criteria for echocardiographic diagnosis of subclinical RHD emphasize the presence of pathological valve regurgitation but do not include valves with morphological features of RHD without pathological regurgitation. We hypothesized that adding morphological features to diagnostic criteria might have significant consequences in terms of case detection rates.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Methods and Results\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    We screened 2170 randomly selected school children aged 6 to 17 years in Maputo, Mozambique, clinically and by a portable ultrasound system. Two different echocardiographic sets of criteria for RHD were assessed: \u201cWHO\u201d (exclusively Doppler-based) and \u201ccombined\u201d (Doppler and morphology-based) criteria. Independent investigators reviewed all suspected RHD cases using a higher-resolution, nonportable ultrasound system. On-site echocardiography identified 18 and 124 children with suspected RHD according to WHO and combined criteria, respectively. After consensus review, 17 were finally considered to have definite RHD according to WHO criteria, and 66 had definite RHD according to combined criteria, giving prevalence rates of 7.8 (95% confidence interval, 4.6 to 12.5) and 30.4 (95% confidence interval, 23.6 to 38.5) per 1000 children, respectively (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.0001, exact McNemar test).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Conclusions\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    Important consideration should be given to echocardiographic criteria for detecting subclinical RHD because the number of cases detected may differ importantly according to the diagnostic criteria utilized. Currently recommended WHO criteria risk missing up to three quarters of cases of subclinically affected and therefore potentially treatable children with RHD.\n                  <\/jats:p>","DOI":"10.1161\/circulationaha.109.849190","type":"journal-article","created":{"date-parts":[[2009,8,10]],"date-time":"2009-08-10T21:28:49Z","timestamp":1249939729000},"page":"663-668","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":121,"title":["Rheumatic Heart Disease Screening by Echocardiography"],"prefix":"10.1161","volume":"120","author":[{"given":"Eloi","family":"Marijon","sequence":"first","affiliation":[{"name":"From Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., X.J.); Paris Cardiovascular Research Center, INSERM 970, Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., M.T., X.J.); Department of Medicine, Sydney University, Sydney, Australia (D.S.C.); INSERM UMRS-956, Universite\u0301 Pierre et Marie Curie, Paris, France (S.E.H.); Instituto do Corac\u0327a\u0303o, Maputo, Mozambique (D.N.J., B.F., A.O.M., D.S.); Institut de Veille..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Celermajer","sequence":"additional","affiliation":[{"name":"From Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., X.J.); Paris Cardiovascular Research Center, INSERM 970, Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., M.T., X.J.); Department of Medicine, Sydney University, Sydney, Australia (D.S.C.); INSERM UMRS-956, Universite\u0301 Pierre et Marie Curie, Paris, France (S.E.H.); Instituto do Corac\u0327a\u0303o, Maputo, Mozambique (D.N.J., B.F., A.O.M., D.S.); Institut de Veille..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Tafflet","sequence":"additional","affiliation":[{"name":"From Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., X.J.); Paris Cardiovascular Research Center, INSERM 970, Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., M.T., X.J.); Department of Medicine, Sydney University, Sydney, Australia (D.S.C.); INSERM UMRS-956, Universite\u0301 Pierre et Marie Curie, Paris, France (S.E.H.); Instituto do Corac\u0327a\u0303o, Maputo, Mozambique (D.N.J., B.F., A.O.M., D.S.); Institut de Veille..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai\u0308d","family":"El-Haou","sequence":"additional","affiliation":[{"name":"From Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., X.J.); Paris Cardiovascular Research Center, INSERM 970, Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., M.T., X.J.); Department of Medicine, Sydney University, Sydney, Australia (D.S.C.); INSERM UMRS-956, Universite\u0301 Pierre et Marie Curie, Paris, France (S.E.H.); Instituto do Corac\u0327a\u0303o, Maputo, Mozambique (D.N.J., B.F., A.O.M., D.S.); Institut de Veille..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh N.","family":"Jani","sequence":"additional","affiliation":[{"name":"From Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., X.J.); Paris Cardiovascular Research Center, INSERM 970, Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., M.T., X.J.); Department of Medicine, Sydney University, Sydney, Australia (D.S.C.); INSERM UMRS-956, Universite\u0301 Pierre et Marie Curie, Paris, France (S.E.H.); Instituto do Corac\u0327a\u0303o, Maputo, Mozambique (D.N.J., B.F., A.O.M., D.S.); Institut de Veille..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Ferreira","sequence":"additional","affiliation":[{"name":"From Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., X.J.); Paris Cardiovascular Research Center, INSERM 970, Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., M.T., X.J.); Department of Medicine, Sydney University, Sydney, Australia (D.S.C.); INSERM UMRS-956, Universite\u0301 Pierre et Marie Curie, Paris, France (S.E.H.); Instituto do Corac\u0327a\u0303o, Maputo, Mozambique (D.N.J., B.F., A.O.M., D.S.); Institut de Veille..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Olga","family":"Mocumbi","sequence":"additional","affiliation":[{"name":"From Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., X.J.); Paris Cardiovascular Research Center, INSERM 970, Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., M.T., X.J.); Department of Medicine, Sydney University, Sydney, Australia (D.S.C.); INSERM UMRS-956, Universite\u0301 Pierre et Marie Curie, Paris, France (S.E.H.); Instituto do Corac\u0327a\u0303o, Maputo, Mozambique (D.N.J., B.F., A.O.M., D.S.); Institut de Veille..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Paquet","sequence":"additional","affiliation":[{"name":"From Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., X.J.); Paris Cardiovascular Research Center, INSERM 970, Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., M.T., X.J.); Department of Medicine, Sydney University, Sydney, Australia (D.S.C.); INSERM UMRS-956, Universite\u0301 Pierre et Marie Curie, Paris, France (S.E.H.); Instituto do Corac\u0327a\u0303o, Maputo, Mozambique (D.N.J., B.F., A.O.M., D.S.); Institut de Veille..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sidi","sequence":"additional","affiliation":[{"name":"From Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., X.J.); Paris Cardiovascular Research Center, INSERM 970, Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., M.T., X.J.); Department of Medicine, Sydney University, Sydney, Australia (D.S.C.); INSERM UMRS-956, Universite\u0301 Pierre et Marie Curie, Paris, France (S.E.H.); Instituto do Corac\u0327a\u0303o, Maputo, Mozambique (D.N.J., B.F., A.O.M., D.S.); Institut de Veille..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Jouven","sequence":"additional","affiliation":[{"name":"From Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., X.J.); Paris Cardiovascular Research Center, INSERM 970, Universite\u0301 Paris Descartes, AP-HP, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France (E.M., M.T., X.J.); Department of Medicine, Sydney University, Sydney, Australia (D.S.C.); INSERM UMRS-956, Universite\u0301 Pierre et Marie Curie, Paris, France (S.E.H.); Instituto do Corac\u0327a\u0303o, Maputo, Mozambique (D.N.J., B.F., A.O.M., D.S.); Institut de Veille..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66874-2"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1381.045"},{"key":"e_1_3_2_3_2","first-page":"1153","volume":"333","year":"2006","unstructured":"Cilliers AM. Rheumatic fever and its management. BMJ. 2006; 333: 1153\u20131156.","journal-title":"BMJ"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.07.046680"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2004.057570"},{"key":"e_1_3_2_6_2","first-page":"246.","volume":"96","year":"2006","unstructured":"Mayosi B, Robertson K, Volmink J, Adebo W, Akinyore K, Amoah A, Bannerman C, Biesman-Simons S, Carapetis J, Cilliers A, Commerford P, Croasdale A, Damasceno A, Dean J, Dean M, de Souza R, Filipe A, Hugo-Hamman C, Jurgens-Clur SA, Kombila-Koumba P, Kotzenberg C, Lawrenson J, Manga P, Matenga J, Mathivha T, Mntla P, Mocumbi A, Mokone T, Ogola E, Omokhodion S, Palweni C, Pearce A, Salo A, Thomas B, Walker K, Wiysonge C, Zaher S. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J. 2006; 96: 246.","journal-title":"S Afr Med J"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065085"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio1185"},{"key":"e_1_3_2_9_2","unstructured":"WHO. Rheumatic Fever and Rheumatic Heart Disease: Report of a WHO Expert Consultation Geneva 29 October\u20131 November 2001. Geneva Switzerland: World Health Organization; 2004."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2007.141309"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.268.15.2069"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000153388.41229.cb"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e318157725d"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.60.4.299"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05134-5"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.94.1.73"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2007.tb01059.x"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.109.849190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T01:30:36Z","timestamp":1715563836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.109.849190"}},"subtitle":["The Inadequacy of World Health Organization Criteria for Optimizing the Diagnosis of Subclinical Disease"],"short-title":[],"issued":{"date-parts":[[2009,8,25]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8,25]]}},"alternative-id":["10.1161\/CIRCULATIONAHA.109.849190"],"URL":"https:\/\/doi.org\/10.1161\/circulationaha.109.849190","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1163862.625687","asserted-by":"object"}]},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,25]]},"assertion":[{"value":"2009-08-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}